Puma Biotechnology | PBYI - Equity Capital And Reserves


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Puma Biotechnology

Puma Biotechnology reported $25.85M in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.


Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.04B 64.29M
Alnylam Pharmaceuticals ALNY:US USD -259240000 101.02M
Amgen AMGN:US USD 5.35B 1.69B
Biogen BIIB:US USD 13.8B 398.7M
BioMarin Pharmaceutical BMRN:US USD 4.66B 55.89M
Bluebird Bio BLUE:US USD 354.74M 158.4M
Daiichi Sankyo 4568:JP JPY 1.45T 31.53B
Esperion Therapeutics ESPR:US USD -329663000 5.88M
Exelixis EXEL:US USD 2.56B 66.71M
Gilead Sciences GILD:US USD 20.94B 270M
Glaxosmithkline GSK:US GBP 11.82B 1.22B
Incyte Corp INCY:US USD 4.46B 92.45M
Intercept Pharmaceuticals ICPT:US USD 67.18M 25.89M
MacroGenics MGNX:US USD 109.27M 32.74M
Mirati Therapeutics MRTX:US USD 862.63M 133.89M
Moderna Inc MRNA:US USD 18.86B 260M
Novartis NOVN:VX USD 52.06B 7.28B
PTC Therapeutics PTCT:US USD -457561000 110.48M
Puma Biotechnology PBYI:US USD 25.85M 4.24M
Regeneron Pharmaceuticals REGN:US USD 23.5B 831.2M
Roche Holding ROG:VX 27.99B 2.8B
Sangamo BioSciences SGMO:US USD 335.61M 40.65M
Sarepta Therapeutics SRPT:US USD 712.75M 327.8M
Seattle Genetics SGEN:US USD 2.72B 80.66M
Spectrum Pharmaceuticals SPPI:US USD 26.8M 1.08M
Takeda 4502:JP JPY 6.35T 178.14B
TG Therapeutics TGTX:US USD 27.43M 31.15M
Ultragenyx Pharmaceutical RARE:US USD 220.48M 132.01M
Vanda Pharmaceuticals VNDA:US USD 535.74M 8.54M
Vertex Pharmaceuticals VRTX:US USD 14.43B 519.6M